Dynamics and significance of the antibody response to SARS-CoV-2 infection
暂无分享,去创建一个
Galit Alter | Jared Feldman | Stephen A. Lauer | Andrew S. Azman | Zhenfeng Li | A. John Iafrate | Guillaume Mellon | A. Iafrate | S. Lauer | F. K. Jones | A. Azman | G. Alter | M. Kamruzzaman | J. Branda | S. Calderwood | Jason B. Harris | R. Charles | R. LaRocque | E. Ryan | T. Caradonna | A. Schmidt | D. Barouch | S. Fischinger | C. Atyeo | Jingyou Yu | J. Feldman | B. Hauser | S. Turbett | Edward T Ryan | Regina C. LaRocque | Stephen B. Calderwood | Dan H. Barouch | Mohammad Kamruzzaman | Blake M. Hauser | Timothy M. Caradonna | Aaron G. Schmidt | T. Miller | Richelle C. Charles | D. Slater | Diane Yang | M. Astudillo | Diane Yang | Anita S. Iyer | Forrest K. Jones | Ariana Nodoushani | Meagan Kelly | Margaret Becker | Damien Slater | Rachel Mills | Erica Teng | Wilfredo F. Garcia-Beltran | Michael Astudillo | Tyler E. Miller | Elizabeth Oliver | Stephanie Fischinger | Caroline Atyeo | Jingyou Yu | John A. Branda | Sarah E. Turbett | M. Becker | E. Oliver | Meagan Kelly | A. Nodoushani | J. Harris | G. Mellon | A. S. Iyer | Zhenfeng Li | W. García-Beltrán | Rachel Mills | E. Teng | A. Iyer | Elizabeth Oliver | Diane Yang | R. Larocque | A. Schmidt | Meagan Kelly | Margaret Becker
[1] Nicola Clementi,et al. Poor correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects , 2020, medRxiv.
[2] X. Tang,et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections , 2020, Nature Medicine.
[3] G. Alter,et al. Dissecting antibody-mediated protection against SARS-CoV-2 , 2020, Nature Reviews Immunology.
[4] P. Sorger,et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques , 2020, Science.
[5] R. Baric,et al. DNA vaccine protection against SARS-CoV-2 in rhesus macaques , 2020, Science.
[6] A. Azman,et al. Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward , 2020, Science Immunology.
[7] F. Grosveld,et al. Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection , 2020, Nature Communications.
[8] L. Kucirka,et al. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.
[9] D. R. Walt,et al. Ultra-Sensitive High-Resolution Profiling of Anti-SARS-CoV-2 Antibodies for Detecting Early Seroconversion in COVID-19 Patients , 2020, medRxiv.
[10] Po Ying Chia,et al. Connecting clusters of COVID-19: an epidemiological and serological investigation , 2020, The Lancet Infectious Diseases.
[11] C. Boesecke,et al. Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity , 2020, Public Health.
[12] D. Cummings,et al. A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease , 2020, medRxiv.
[13] Qi Jin,et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] M. Lipsitch,et al. Defining the Epidemiology of Covid-19 - Studies Needed. , 2020, The New England journal of medicine.
[15] Clifford Anderson-Bergman,et al. icenReg: Regression Models for Interval Censored Data in R , 2017 .
[16] I. Jo,et al. Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity , 2017, Diagnostic Microbiology and Infectious Disease.